Induced pluripotent stem cells and hepatic differentiation |
| |
| Authors: | Chih-Hung Chiang Teh-Ia Huo Cho-Chin Sun Jung-Hung Hsieh Yueh Chien Kai-Hsi Lu Shou-Dong Lee |
| |
| Institution: | 1. Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan, ROC;2. Division of Urology, Department of Surgery, Taipei Veterans General Hospital and Su-Ao/Yuan-Shan Branch, Yi-Lan, Taiwan, ROC;3. Division of Gastroenterology, Department of Internal Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC;4. Department of Medical Research and Education, Cheng-Hsin General Hospital, Taipei, Taiwan, ROC;5. National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC;6. Graduate Institute of Basic Medicine, Fu Jen Catholic University, New Taipei City, Taiwan, ROC;7. Division of Gastroenterology, Department of Medicine, Cheng Hsin General Hospital, Taipei, Taiwan, ROC |
| |
| Abstract: | Induced pluripotent stem cells (iPSCs) are generated by reprogramming somatic cells to a pluripotent state by the introduction of specific factors. They can be generated from cells of different origins, such as fibroblasts, keratinocytes, hepatocytes, and blood. iPSCs are similar to embryonic stem cells (ESCs) in several aspects, such as morphology, expression of pluripotency markers, and the ability to develop teratoma that contains tissue from three germ layers. In addition, iPSCs can undergo tridermal differentiation, including hepatic specific lineages. Considering that iPSCs could be a source of hepatocyte regeneration, iPSC-based therapy has been widely implicated in the treatment of liver disease and hepatic regeneration. In the present review, we discuss the therapeutic potential of iPSCs in hepatic repair and focus on the clinical applications of iPSCs. |
| |
| Keywords: | hepatic repair induced pluripotent stem cells |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
